Cannabis Science, Inc. Announces 420 Commemorative Certificate Program
ADDISON, Texas--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: GFON.OB) announced its 420 Commemorative Certificate Program and that it has engaged Capital Structure Today to provide it with branding and public/investor awareness services.
April 20 is the New Years Day of cannabis culture. Activists, recreational users and other socially conscious members of the world-wide community stop their work or play at 4:20 p.m. and share in an herbal communion. In recognition of the importance and relevance of this day to our Company's mission, we've launched our 420 Commemorative Certificate Program. Shareholders who own the Company's common stock on April 20, 2009, are eligible to purchase a limited edition Commemorative Certificate from our transfer agent, Routh Stock Transfer, Inc., properly framed and righteously dated. A specimen sample certificate and instructions to obtain your Commemorative Certificate will be posted to our website at www.cannabisscience.com in the next few days after final approval of the artwork. The 420 Commemorative Certificate Program will be limited to 500 certificates this year, each hand signed by President Steven W. Kubby.
Vice President and Chief Financial Officer Richard Cowan stated, "During my tenure as National Director of NORML, we looked forward to April 20 each year to re-commit the activist community and re-connect with the recreational user and others who shared the national organization's goals. For the last 30 years, 420 has been an integral part of cannabis culture, and I know that NORML still emphasizes its observance for lots of reasons and in lots of venues. Here at Cannabis Science, Inc., our commercial goal is to develop and market FDA-approved and OTC cannabis-based medicines employing our proprietary lozenge delivery system. This goal stands on the foundation that our President, Steve Kubby, NORML and other cannabis activist organizations have built on a state-by-state basis, a large part of which has been based on the recognition and advancement of the clinical use of medical marijuana for a broad range of illnesses and for general health maintenance. We want to approach these issues from a commercial, profit-driven objective. That said, 420 is an important reminder for all of us to keep the faith and build bridges to those that don't yet see things the way we do, and we think the 420 Commemorative Certificate is a great reminder that our shareholders will appreciate all year long."
CST's work will be predominantly oriented toward social networking with financial professionals and medical cannabis activists. The firm has extensive follows, friends, streams and fans in Twitter, MySpace, Plurk and Facebook, as well as competence in establishing and maintaining groups in Digg, Stumbleupon and others.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
About Capital Structure Today, Inc.
Capital Structure Today is a multimedia marketing and advertising firm that offers various corporate services and specializes in bringing small and micro-cap companies to the attention of the general public. Our focus is primarily on small, privately held corporations as well as micro-cap publicly traded corporations that have a need for cost effective, creative, innovative marketing and advertising strategies. CST has a team of seasoned professionals that has developed an extensive presence in the various social media forums and as such we offer various services designed to increase brand and name recognition of the companies we represent.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," "intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.